The skeletal muscle arachidonic acid cascade in health and inflammatory disease

Nature Reviews Rheumatology

Volumn 10, Issue 5, 2014, Pages 295-303

  Korotkova, Marina ^a   Lundberg, Ingrid E ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; LEUKOTRIENE; LEUKOTRIENE B4; PROSTACYCLIN; PROSTAGLANDIN; PROSTAGLANDIN D2; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA;

ARACHIDONIC ACID CASCADE; CHRONIC INFLAMMATION; DISEASE ASSOCIATION; HUMAN; INFLAMMATORY DISEASE; METABOLISM; METABOLITE; MUSCLE ATROPHY; MUSCLE FUNCTION; MUSCLE GROWTH; MUSCLE STRENGTH; MUSCLE WEAKNESS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; REGULATORY MECHANISM; REVIEW; SKELETAL MUSCLE; MYOSITIS; PHYSIOLOGY; CELL HYPOXIA; CELL PROLIFERATION; DUCHENNE MUSCULAR DYSTROPHY; GENE OVEREXPRESSION; MUSCLE DEVELOPMENT; MYOBLAST; MYOTUBE; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ARACHIDONIC ACID; HUMANS; LEUKOTRIENES; MUSCLE, SKELETAL; MYOSITIS; PROSTAGLANDINS;

EID: 84899947018     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2014.2     Document Type: Review

References (91)

1. Mastaglia, F. L., Garlepp, M. J., Phillips, B. A. & Zilko, P. J. Inflammatory myopathies: Clinical, diagnostic and therapeutic aspects. Muscle Nerve 27, 407-425 (2003
2. Lundberg, I., Ulfgren, A. K., Nyberg, P., Andersson, U. & Klareskog, L. Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies. Arthritis Rheum. 40, 865-874 (1997
3. Nyberg, P., Wikman, A. L., Nennesmo, I. & Lundberg, I. Increased expression of interleukin 1? and MHC class I in muscle tissue of patients with chronic, inactive polymyositis and dermatomyositis. J. Rheumatol. 27, 940-948 (2000
4. Figarella-Branger, D., Civatte, M., Bartoli, C. & Pellissier, J. F. Cytokines, chemokines, and cell adhesion molecules in inflammatory myopathies. Muscle Nerve 28, 659-682 (2003
5. Zong, M. & Lundberg, I. E. Pathogenesis, classification and treatment of inflammatory myopathies. Nat. Rev. Rheumatol. 7, 297-306 (2011
6. Nagaraju, K. & Lundberg, I. E. Polymyositis and dermatomyositis: Pathophysiology. Rheum. Dis. Clin. North. Am. 37, 159-171 (2011
7. Prisk, V. & Huard, J. Muscle injuries and repair: The role of prostaglandins and inflammation. Histol. Histopathol. 18, 1243-1256 (2003
8. Sun, R., Ba, X., Cui, L., Xue, Y. & Zeng, X. Leukotriene B4 regulates proliferation and differentiation of cultured rat myoblasts via the BLT1 pathway. Mol. Cells 27, 403-408 (2009
9. Loell, I. et al. Activated LTB4 pathway in muscle tissue of patients with polymyositis or dermatomyositis. Ann. Rheum. Dis. 72, 293-299 (2013
10. Jakobsson, P. J., Thoren, S., Morgenstern, R. & Samuelsson, B. Identification of human prostaglandin E synthase: A microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target. Proc. Natl Acad. Sci. USA 96, 7220-7225 (1999
11. Thoren, S. et al. Human microsomal prostaglandin E synthase 1: Purification, functional characterization and projection structure determination. J. Biol. Chem. 278, 22199-22209 (2003
12. Murakami, M. et al. Regulation of prostaglandin E2 biosynthesis by inducible membrane-Associated prostaglandin E2 synthase that acts in concert with cyclooxygenase 2. J. Biol. Chem. 275, 32783-32792 (2000
13. Murakami, M. et al. Cellular prostaglandin E2 production by membrane-bound prostaglandin E synthase 2 via both cyclooxygenases 1 and 2.J. Biol. Chem. 278, 37937-37947 (2003
14. Tanioka, T., Nakatani, Y., Semmyo, N., Murakami, M. & Kudo, I. Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase 1 in immediate prostaglandin E2 biosynthesis. J. Biol. Chem. 275, 32775-32782 (2000
15. Berlin, T., Cronestrand, R., Nowak, J., Sonnenfeld, T. & Wennmalm, A. Conversion of arachidonic acid to prostaglandins in homogenates of human skeletal muscle and kidney. Acta Physiol. Scand. 106, 441-445 (1979
16. Nowak, J. et al. Biosynthesis of prostaglandins in microsomes of human skeletal muscle and kidney. Prostaglandins Leukot. Med. 11, 269-279 (1983
17. Karamouzis, M. et al. In situ microdialysis of intramuscular prostaglandin and thromboxane in contracting skeletal muscle in humans. Acta Physiol. Scand. 171, 71-76 (2001
18. Zalin, R. J. The role of hormones and prostanoids in the in vitro proliferation and differentiation of human myoblasts. Exp. Cell Res. 172, 265-281 (1987
19. Otis, J. S., Burkholder, T. J. & Pavlath, G. K. Stretch-induced myoblast proliferation is dependent on the COX2 pathway. Exp. Cell Res. 310, 417-425 (2005
20. McElligott, M. A., Chaung, L. Y., Baracos, V. & Gulve, E. A. Prostaglandin production in myotube cultures. Influence on protein turnover. Biochem. J. 253, 745-749 (1988
21. Bondesen, B. A., Jones, K. A., Glasgow, W. C. & Pavlath, G. K. Inhibition of myoblast migration by prostacyclin is associated with enhanced cell fusion. FASEB J. 21, 3338-3345 (2007
22. Velica, P., Khanim, F. L. & Bunce, C. M. Prostaglandin D2 inhibits C2C12 myogenesis. Mol.Cell. Endocrinol. 319, 71-78 (2010
23. Testa, M. et al. Expression and activity of cyclooxygenase isoforms in skeletal muscles and myocardium of humans and rodents. J. Appl. Physiol. 103, 1412-1418 (2007
24. Weinheimer, E. M. et al. Resistance exercise and cyclooxygenase (COX) expression in human skeletal muscle: Implications for COX-inhibiting drugs and protein synthesis. Am. J. Physiol. Regul. Integr. Comp. Physiol. 292, R2241-R2248 (2007
25. Studynkova, J. T. et al. The expression of cyclooxygenase 1, cyclooxygenase 2 and 5 lipoxygenase in inflammatory muscle tissue of patients with polymyositis and dermatomyositis. Clin. Exp. Rheumatol. 22, 395-402 (2004
26. Buford, T. W. et al. Effects of eccentric treadmill exercise on inflammatory gene expression in human skeletal muscle. Appl. Physiol. Nutr. Metab. 34, 745-753 (2009
27. Rabuel, C. et al. Human septic myopathy: Induction of cyclooxygenase, heme oxygenase and activation of the ubiquitin proteolytic pathway. Anesthesiology 101, 583-590 (2004
28. Sudbo, J. et al. COX 2 expression in striated muscle under physiological conditions. Oral Dis. 9, 313-316 (2003
29. Korotkova, M. et al. Effects of immunosuppressive treatment on microsomal prostaglandin E synthase 1 and cyclooxygenases expression in muscle tissue of patients with polymyositis or dermatomyositis. Ann. Rheum. Dis. 67, 1596-1602 (2008
30. Jansen, K. M. & Pavlath, G. K. Prostaglandin F2? promotes muscle cell survival and growth through upregulation of the inhibitor of apoptosis protein BRUCE. Cell Death Differ. 15, 1619-1628 (2008
31. Horsley, V. & Pavlath, G. K. Prostaglandin F2? stimulates growth of skeletal muscle cells via an NFATC2-dependent pathway. J. Cell. Biol. 161, 111-118 (2003
32. Markworth, J. F. & Cameron-Smith, D. Prostaglandin F2? stimulates PI3K/ERK/mTOR signaling and skeletal myotube hypertrophy. Am. J. Physiol. Cell Physiol. 300, C671-C682 (2011
33. Shen, W., Prisk, V. R., Li, Y., Foster, W. & Huard, J. Inhibited skeletal muscle healing in cyclooxygenase 2 gene-deficient mice: The role of PGE2 and PGF2?. J. Appl. Physiol. 101, 1215-1221 (2006
34. Mo, C., Romero-Suarez, S., Bonewald, L., Johnson, M. & Brotto, M. Prostaglandin E2: From clinical applications to its potential role in bone-muscle crosstalk and myogenic differentiation. Recent Pat. Biotechnol. 6, 223-229 (2012
35. Hunter, J. G., van Delft, M. F., Rachubinski, R. A. & Capone, J. P. Peroxisome proliferator-Activated receptor gamma ligands differentially modulate muscle cell differentiation and MyoD gene expression via peroxisome proliferator-Activated receptor gamma -dependent and -independent pathways. J. Biol. Chem. 276, 38297-38306 (2001
36. Markworth, J. F. & Cameron-Smith, D. Arachidonic acid supplementation enhances in vitro skeletal muscle cell growth via a COX 2 dependent pathway. Am. J. Physiol. Cell Physiol. 304, C56-C67 (2013
37. Mendias, C. L., Tatsumi, R. & Allen, R. E. Role of cyclooxygenase 1 and 2 in satellite cell proliferation, differentiation, and fusion. Muscle Nerve 30, 497-500 (2004
38. Bondesen, B. A., Mills, S. T., Kegley, K. M. & Pavlath, G. K. The COX 2 pathway is essential during early stages of skeletal muscle regeneration. Am. J. Physiol. Cell Physiol. 287, C475-C483 (2004
39. Bondesen, B. A., Mills, S. T. & Pavlath, G. K. The COX 2 pathway regulates growth of atrophied muscle via multiple mechanisms. Am. J. Physiol. Cell Physiol. 290, 1651-1659 (2006
40. Trappe, T. A., Fluckey, J. D., White, F., Lambert, C. P. & Evans, W. J. Skeletal muscle PGF2? and PGE2 in response to eccentric resistance exercise: Influence of ibuprofen acetaminophen. J. Clin. Endocrinol. Metab. 86, 5067-5070 (2001
41. Mikkelsen, U. R. et al. Local NSAID infusion does not affect protein synthesis and gene expression in human muscle after eccentric exercise. Scand. J. Med. Sci. Sports 21, 630-644 (2011
42. Reeds, P. J. & Palmer, R. M. Changes in prostaglandin release associated with inhibition of muscle protein synthesis by dexamethasone. Biochem. J. 219, 953-957 (1984
43. Southorn, B. G. & Palmer, R. M. Inhibitors of phospholipase A2 block the stimulation of protein synthesis by insulin in L6 myoblasts. Biochem. J. 270, 737-739 (1990
44. Chromiak, J. A. & Vandenburgh, H. H. Mechanical stimulation of skeletal muscle cells mitigates glucocorticoid-induced decreases in prostaglandin production and prostaglandin synthase activity. J. Cell. Physiol. 159, 407-414 (1994
45. Kreiner, F. & Galbo, H. Elevated muscle interstitial levels of pain-inducing substances in symptomatic muscles in patients with polymyalgia rheumatica. Pain 152, 1127-1132 (2011
46. Symons, J. D., Theodossy, S. J., Longhurst, J. C. & Stebbins, C. L. Intramuscular accumulation of prostaglandins during static contraction of the cat triceps surae. J. Appl. Physiol.71, 1837-1842 (1991
47. Wilson, J. R. & Kapoor, S. C. Contribution of prostaglandins to exercise-induced vasodilation in humans. Am. J. Physiol. 265, H171-H175 (1993
48. Young, M. K., Bocek, R. M., Herrington, P. T. & Beatty, C. H. Aging: Effects on the prostaglandin production by skeletal muscle of male rhesus monkeys (Macaca mulatta). Mech. Ageing Dev. 16, 345-353 (1981
49. Kozlovsky, N., Shohami, E. & Bashan, N. Increased PLA2 activity is not related to increase GLUT1 expression in L6 myotubes under hypoxic conditions. Prostaglandins Leukot. Essent. Fatty Acids 56, 17-22 (1997
50. McArdle, A., Edwards, R. H. & Jackson, M. J. Release of creatine kinase and prostaglandin E2 from regenerating skeletal muscle fibers. J. Appl. Physiol. 76, 1274-1278 (1994
51. Briolay, A., Jaafar, R., Nemoz, G. & Bessueille, L. Myogenic differentiation and lipid-raft composition of L6 skeletal muscle cells are modulated by PUFAs. Biochim. Biophys. Acta 1828, 602-613 (2012
52. Hurley, M. S., Flux, C., Salter, A. M. & Brameld, J. M. Effects of fatty acids on skeletal muscle cell differentiation in vitro. Br. J. Nutr. 95, 623-630 (2006
53. Lee, J. H., Tachibana, H., Morinaga, Y., Fujimura, Y. & Yamada, K. Modulation of proliferation and differentiation of C2C12 skeletal muscle cells by fatty acids. Life Sci. 84, 415-420 (2009
54. Kadotani, A., Tsuchiya, Y., Hatakeyama, H., Katagiri, H. & Kanzaki, M. Different impacts of saturated and unsaturated free fatty acids on COX 2 expression in C2C12 myotubes. Am. J. Physiol. Endocrinol. Metab. 297, E1291-E1303 (2009
55. McArdle, A., Foxley, A., Edwards, R. H. & Jackson, M. J. Prostaglandin metabolism in dystrophin-deficient MDX mouse muscle. Biochem. Soc. Trans. 19, 177S (1991
56. Jackson, M. J., Brooke, M. H., Kaiser, K. & Edwards, R. H. Creatine kinase and prostaglandin E2 release from isolated Duchenne muscle. Neurology 41, 101-104 (1991
57. Lindahl, M., Backman, E., Henriksson, K. G., Gorospe, J. R. & Hoffman, E. P. Phospholipase A2 activity in dystrophinopathies. Neuromuscul. Disord. 5, 193-199 (1995
58. Okinaga, T. et al. Induction of hematopoietic prostaglandin D synthase in hyalinated necrotic muscle fibers: Its implication in grouped necrosis. Acta Neuropathol. 104, 377-384 (2002
59. Mohri, I. et al. Inhibition of prostaglandin D synthase suppresses muscular necrosis. Am. J. Pathol. 174, 1735-1744 (2009
60. Turinsky, J., O'Sullivan, D. M. & Bayly, B. P. Modulation of prostaglandin E2 synthesis in rat skeletal muscle. Am. J. Physiol. 262, E476-482 (1992
61. Jaweed, M. M., Alam, I., Herbison, G. J. & Ditunno, J. F. Jr. Prostaglandins in denervated skeletal muscle of the rat: Effect of direct electrical stimulation. Neuroscience 6, 2787-2792 (1981
62. Turinsky, J. Phospholipids, prostaglandin E2, and proteolysis in denervated muscle. Am. J. Physiol. 251, R165-R173 (1986
63. Murray, M. A. & Robbins, N. Cell proliferation in denervated muscle: Identity and origin of dividing cells. Neuroscience 7, 1823-1833 (1982
64. Tegeder, L., Zimmermann, J., Meller, S. T. & Geisslinger, G. Release of algesic substances in human experimental muscle pain. Inflamm. Res. 51, 393-402 (2002
65. Hedenberg-Agnusson, B., Ernberg, M., Alstergren, P. & Kopp, S. Pain mediation by prostaglandin E2 and leukotriene B4 in the human masseter muscle. Acta Odontol. Scand. 59, 348-355 (2001
66. Rodemann, H. P. & Goldberg, A. L. Arachidonic acid, prostaglandin E2 and F2 alpha influence rates of protein turnover in skeletal and cardiac muscle. J. Biol. Chem. 257, 1632-1638 (1982
67. Rodemann, H. P., Waxman, L. & Goldberg, A. L. The stimulation of protein degradation in muscle by Ca2+ is mediated by prostaglandin E2 and does not require the calcium-Activated protease. J. Biol. Chem. 257, 8716-8723 (1982
68. Barnett, J. G. & Ellis, S. Prostaglandin E2 and the regulation of protein degradation in skeletal muscle. Muscle Nerve 10, 556-559 (1987
69. Hasselgren, P. O., Zamir, O., James, J. H. & Fischer, J. E. Prostaglandin E2 does not regulate total or myofibrillar protein breakdown in incubated skeletal muscle from normal or septic rats. Biochem. J. 270, 45-50 (1990
70. Rieu, I. et al. Reduction of low grade inflammation restores blunting of postprandial muscle anabolism and limits sarcopenia in old rats. J. Physiol. 587, 5483-5492 (2009
71. Granado, M., Martin, A. I., Villanua, M. A. & Lopez-Calderon, A. Experimental arthritis inhibits the insulin-like growth factor I axis and induces muscle wasting through cyclooxygenase 2 activation. Am. J. Physiol. Endocrinol. Metab. 292, E1656-E1665 (2007
72. Strelkov, A. B., Fields, A. L. & Baracos, V. E. Effects of systemic inhibition of prostaglandin production on protein metabolism in tumor-bearing rats. Am. J. Physiol. 257, C261-C269 (1989
73. McCarthy, D. O., Whitney, P., Hitt, A. & Al-Majid, S. Indomethacin and ibuprofen preserve gastrocnemius muscle mass in mice bearing the colon 26 adenocarcinoma. Res. Nurs. Health 27, 174-184 (2004
74. Trappe, T. A., Standley, R. A., Jemiolo, B., Carroll, C. C. & Trappe, S. W. Prostaglandin and myokine involvement in the cyclooxygenase-inhibiting drug enhancement of skeletal muscle adaptations to resistance exercise in older adults. Am. J. Physiol. Regul. Integr. Comp. Physiol. 304, R198-R205 (2013
75. Standley, R. A., Liu, S. Z., Jemiolo, B., Trappe, S. W. & Trappe, T. A. Prostaglandin E2 induces transcription of skeletal muscle mass regulators interleukin 6 and muscle RING finger 1 in humans. Prostaglandins Leukot. Essent. Fatty Acids 88, 361-364 (2013
76. Baracos, V., Rodemann, H. P., Dinarello, C. A. & Goldberg, A. L. Stimulation of muscle protein degradation and prostaglandin E2 release by leukocytic pyrogen (interleukin 1). A mechanism for the increased degradation of muscle proteins during fever. N. Engl. J. Med. 308, 553-558 (1983
77. Schafers, M., Sorkin, L. S. & Sommer, C. Intramuscular injection of tumor necrosis factor-Alpha induces muscle hyperalgesia in rats. Pain 104, 579-588 (2003
78. Schneider, A. et al. Membrane-Associated PGE synthase 1 (mPGES 1) is coexpressed with both COX 1 and COX 2 in the kidney. Kidney Int. 65, 1205-1213 (2004
79. Boulet, L. et al. Deletion of microsomal prostaglandin E2 (PGE2) synthase 1 reduces inducible and basal PGE2 production and alters the gastric prostanoid profile. J. Biol. Chem. 279, 23229-23237 (2004
80. Lundberg, I., Kratz, A. K., Alexanderson, H. & Patarroyo, M. Decreased expression of interleukin-1alpha, interleukin-1beta, and cell adhesion molecules in muscle tissue following corticosteroid treatment in patients with polymyositis and dermatomyositis. Arthritis Rheum. 43, 336-348 (2000
81. Helliwell, P. S. & Jackson, S. Relationship between weakness and muscle wasting in rheumatoid arthritis. Ann. Rheum. Dis 53, 726-728 (1994
82. Stenstrom, C. H. & Minor, M. A. Evidence for the benefit of aerobic and strengthening exercise in rheumatoid arthritis. Arthritis Rheum. 49, 428-434 (2003
83. Donaldson, A. V., Maddocks, M., Martolini, D., Polkey, M. I. & Man, W. D. Muscle function in COPD: A complex interplay. Int. J. Chron. Obstruct. Pulmon. Dis. 7, 523-535 (2012
84. Turesson, C. et al. Increased endothelial expression of HLA-DQ and interleukin 1? in extra-Articular rheumatoid arthritis. Results from immunohistochemical studies of skeletal muscle. Rheumatology 40, 1346-1354 (2001
85. Bhattacharya, A. et al. Genetic ablation of 12/15-lipoxygenase but not 5 lipoxygenase protects against denervation-induced muscle atrophy. Free Radic. Biol. Med. 67, 30-40 (2013
86. Young, J. F., Hansen-Moller, J. & Oksbjerg, N. Effect of flavonoids on stress responses in myotube cultures. J. Agric. Food Chem. 52, 7158-7163 (2004
87. Tager, A. M. et al. Leukotriene B4 receptor BLT1 mediates early effector T cell recruitment. Nat. Immunol. 4, 982-990 (2003
88. Liu, A., Claesson, H. E., Mahshid, Y., Klein, G. & Klein, E. Leukotriene B4 activates T cells that inhibit B cell proliferation in EBV-infected cord blood-derived mononuclear cell cultures. Blood 111, 2693-2703 (2008
89. Chen, H. et al. Effects of leukotriene B4 and prostaglandin E2 on the differentiation of murine Foxp3+ T regulatory cells and Th17 cells. Prostaglandins Leukot. Essent. Fatty Acids 80, 195-200 (2009
90. Ricciotti, E. & FitzGerald, G. A. Prostaglandins and inflammation. Arteriosc. Throm. Vascul. Biol. 31, 986-1000 (2011
91. Nakamura, M. & Shimizu, T. Leukotriene receptors. Chem. Rev. 111, 6231-6298 (2011